Sonochemotherapy: From bench to bedside

Bart H.A. Lammertink*, Clemens Bos, Roel Deckers, Gert Storm, Chrit T.W. Moonen, Jean-Michel Escoffre

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

77 Citations (Scopus)
78 Downloads (Pure)


The combination of microbubbles and ultrasound has emerged as a promising method for local drug delivery. Microbubbles can be locally activated by a targeted ultrasound beam, which can result in several bio-effects. For drug delivery, microbubble-assisted ultrasound is used to increase vascular- and plasma membrane permeability for facilitating drug extravasation and the cellular uptake of drugs in the treated region, respectively. In the case of drug-loaded microbubbles, these two mechanisms can be combined with local release of the drug following destruction of the microbubble. The use of microbubble-assisted ultrasound to deliver chemotherapeutic agents is also referred to as sonochemotherapy. In this review, the basic principles of sonochemotherapy are discussed, including aspects such as the type of (drug-loaded) microbubbles used, the routes of administration used in vivo, ultrasound devices and parameters, treatment schedules and safety issues. Finally, the clinical translation of sonochemotherapy is discussed, including the first clinical study using sonochemotherapy.

Original languageEnglish
Article number138
JournalFrontiers in pharmacology
Issue numberJUN
Publication statusPublished - 2015


  • Chemotherapeutic drug
  • Drug delivery
  • Microbubble
  • Sonochemotherapy
  • Sonoporation
  • Ultrasound


Dive into the research topics of 'Sonochemotherapy: From bench to bedside'. Together they form a unique fingerprint.

Cite this